Zimmer Biomet Holdings, Inc. (ZBH)
NYSE: ZBH · Real-Time Price · USD
100.98
+2.01 (2.03%)
At close: Aug 21, 2026, 4:00 PM EDT
100.57
-0.41 (-0.41%)
After-hours: Aug 21, 2026, 7:30 PM EDT

Zimmer Biomet Holdings Stock Forecast

Stock Price Forecast

According to 27 analysts polled by S&P Global, Zimmer Biomet Holdings stock has a consensus rating of "Buy" and an average price target of $107.57. The average 1-year stock price forecast is 6.53% higher than the current stock price, while the lowest is $93 (-7.90%) and the highest is $130 (+28.74%).

Price Target: $107.57 (+6.53%)
Analyst Consensus: Buy

Price Target

Chart
TargetLowAverageMedianHigh
Price$93$107.57$106$130
Change-7.90%+6.53%+4.97%+28.74%

Analyst Ratings

The average analyst rating for Zimmer Biomet Holdings stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Chart
RatingMar '26Apr '26May '26Jun '26Jul '26Aug '26
Strong Buy666666
Buy222233
Hold171717171818
Sell110000
Strong Sell111100
Total272726262727

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
J.P. Morgan
J.P. Morgan
Hold
Maintains
$117
HoldMaintains$117+15.86%Aug 17, 2026
Citi
Citi
Hold
Maintains
$99
HoldMaintains$99-1.96%Aug 13, 2026
Bank of America Securities
Bank of America Securities
Hold
Maintains
$20$110
HoldMaintains$20$110+8.93%Aug 11, 2026
Truist Financial
Truist Financial
Hold
Maintains
$106
HoldMaintains$106+4.97%Aug 11, 2026
Canaccord Genuity
Canaccord Genuity
Buy
Maintains
$83$100
BuyMaintains$83$100-0.97%Aug 10, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
8.60B
from 8.23B
Increased by 4.43%
Revenue Next Year
8.90B
from 8.60B
Increased by 3.59%
EPS This Year
8.53
from 8.20
Increased by 4.07%
EPS Next Year
9.07
from 8.53
Increased by 6.25%
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
6.83B6.94B7.39B7.68B8.23B8.60B
Revenue Growth
11.42%1.65%6.55%3.85%7.20%4.43%
Gross Profit
4.87B4.92B5.32B5.50B5.74B6.11B
Gross Margin
71.29%70.90%71.93%71.61%69.71%71.11%
Operating Income
1.22B1.29B1.51B1.59B1.40B2.31B
Net Income
401.60M231.40M1.02B903.80M705.10M929.83M
EPS
----8.208.53
EPS Growth
----2.50%4.07%
Forward PE
16.4018.6315.4712.5210.7211.83
Dividend / Share
0.960.960.960.960.960.99
Dividend Growth
-----3.41%
Free Cash Flow
891.55M1.65B1.13B1.06B1.35B1.15B
No. Analysts
-----26
EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue202620272028
High8.6B
Avg8.6B
Low8.5B

Revenue Growth

Revenue Growth202620272028
High
4.8%
Avg
4.4%
Low
3.9%

EPS Forecast

EPS202620272028
High8.57
Avg8.53
Low8.49

EPS Growth

EPS Growth202620272028
High
4.5%
Avg
4.1%
Low
3.5%